Fumihito Hirai - Concepedia

Author

Fumihito Hirai

Also Known As

F Hirai, F. Hirai, F., Hirai, FUMIHITO HIRAI, Fumihito Hirai, H Fumihito, Hirai Fumihito, Hirai, Fumihito, Hirotake Sakuraba, Katsuyuki Fukuda

314

Publications

6.1K

Citations

H-Index

Concepts

All Affiliations

Fukuoka University Toho University Toho University Medical Center Sakura Hospital Kitasato University Hyogo Medical University

About

Fumihito Hirai is an author at Fukuoka University specializing in medicine, gastroenterology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	29	1.8K
2	Gastroenterology	16	21	1.5K
3	Health Sciences	4	4	399
4	Public Health	1	1	14
5	Allergy	1	1	63

Fumihito Hirai

Publications

4.7K

Citations

H-Index

Page 1

	Year	Citations
Evidence-based clinical practice guidelines for inflammatory bowel disease Katsuyoshi Matsuoka, Taku Kobayashi, Fumiaki Ueno, Journal of Gastroenterology	2018	684
Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis Haruhiko Ogata, Jun Kato, Fumihito Hirai, Inflammatory Bowel Diseases	2011	205
Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis Makoto Naganuma, Shinya Sugimoto, Keiichi Mitsuyama, Gastroenterology InflammationFunctional Gastrointestinal DisorderGastroenterologyUlcerative ColitisMedicine	2017	188
White opaque substance within superficial elevated gastric neoplasia as visualized by magnification endoscopy with narrow-band imaging: a new optical sign for differentiating between adenoma and carcinoma Kenshi Yao, Akinori Iwashita, Hiroshi Tanabe, Gastrointestinal Endoscopy Magnification EndoscopyOncologic ImagingOphthalmologyMedical ImagingMedicine	2008	169
Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn’s disease Akira Andoh, Hiroyuki Kuzuoka, Tomoyuki Tsujikawa, Journal of Gastroenterology DysbiosisMulticenter AnalysisGut MicrobiologyGastroenterologyFecal Microbiota Profiles	2012	160
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn’s Disease Bruce E. Sands, Laurent Peyrin‐Biroulet, Jarosław Kierkuś, Gastroenterology Chronic Inflammatory DiseasesCrohn ’ImmunologyGastroenterologyClinical Gastroenterology	2021	143
Adverse reactions to azathioprine cannot be predicted by thiopurine S‐methyltransferase genotype in Japanese patients with inflammatory bowel disease Noritaka Takatsu, Toshiyuki Matsui, Yuji Murakami, Journal of Gastroenterology and Hepatology	2009	141
A Hereditary Enteropathy Caused by Mutations in the SLCO2A1 Gene, Encoding a Prostaglandin Transporter Junji Umeno, Tadakazu Hisamatsu, Motohiro Esaki, PLoS Genetics Slco2a1 GeneProstaglandin TransporterGeneticsImmunologyGastroenterology	2015	141
The ability of a novel blue laser imaging system for the diagnosis of invasion depth of colorectal neoplasms Naohisa Yoshida, Takashi Hisabe, Yutaka Inada, Journal of Gastroenterology Medical ImagingColorectal SurgeryInvasion DepthHistopathologyPathology	2013	135
First trough level of infliximab at week 2 predicts future outcomes of induction therapy in ulcerative colitis—results from a multicenter prospective randomized controlled trial and its post hoc analysis Taku Kobayashi, Yasuo Suzuki, Satoshi Motoya, Journal of Gastroenterology	2015	114

Page 1